A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to demonstrate that dapoxetine can prolong intravaginal
ejaculatory latency time (IELT) compared with placebo in men with premature ejaculation (PE).
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.